Corrigendum to “Butein downregulates chemokine receptor CXCR4 expression and function through...
Transcript of Corrigendum to “Butein downregulates chemokine receptor CXCR4 expression and function through...
Biochemical Pharmacology xxx (2014) xxx–xxx
G Model
BCP-11961; No. of Pages 2
Corrigendum
Corrigendum to ‘‘Butein downregulates chemokine receptor CXCR4expression and function through suppression of NF-kB activationin breast and pancreatic tumor cells’’ [Biochem. Pharmacol.80 (2010) 1553–1562]
Angeline Wei Ling Chua a,1, Hui Sin Hay a,e,1, Peramaiyan Rajendran a,Muthu K. Shanmugam a, Feng Li a, Pradeep Bist c,d, Evelyn S.C. Koay b, Lina H.K. Lim c,d,Alan Prem Kumar a,e,**, Gautam Sethi a,*a Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singaporeb Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singaporec Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapored Immunology Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singaporee Cancer Science Institute of Singapore, National University of Singapore, Singapore 117456, Singapore
The authors have noticed that the Figs. 5(A) and 6(A) are incorrect: ‘‘CXCL12’’ and ‘‘Butein + CXCL1200 images of lower magnificationwere erroneously published instead of images of ‘‘Control’’ and ‘‘Butein’’. The correct figures are printed below.
The validity of the results and conclusions of the paper are not affected.The authors apologize for any inconvenience.
DOI of original article: http://dx.doi.org/10.1016/j.bcp.2010.07.045
* Corresponding author. Tel.: +65 65163267; fax: +65 68737690.
E-mail addresses: [email protected] (A.P. Kumar), [email protected] (G. Sethi).
Contents lists available at ScienceDirect
Biochemical Pharmacology
jo u rn al h om epag e: ww w.els evier .c o m/lo cat e/b io c hem p har m
** Corresponding author at: Cancer Science Institute of Singapore, National University of Singapore, 28 Medical Drive, Singapore 117456, Singapore. Tel.: +65 6516 5456;
fax: +65 6873 9664.
E-mail addresses: [email protected] (A.P. Kumar), [email protected] (G. Sethi).1 The first two authors contributed equally to this work.
Please cite this article in press as: Chua AWL, et al. Corrigendum to ‘‘Butein downregulates chemokine receptor CXCR4 expression andfunction through suppression of NF-kB activation in breast and pancreatic tumor cells’’ [Biochem. Pharmacol. 80 (2010) 1553–1562].Biochem Pharmacol (2014), http://dx.doi.org/10.1016/j.bcp.2014.04.013
http://dx.doi.org/10.1016/j.bcp.2014.04.013
0006-2952/� 2014 Elsevier Inc. All rights reserved.
Fig. 5.
Fig. 6.
A.W.L. Chua et al. / Biochemical Pharmacology xxx (2014) xxx–xxx2
G Model
BCP-11961; No. of Pages 2
Please cite this article in press as: Chua AWL, et al. Corrigendum to ‘‘Butein downregulates chemokine receptor CXCR4 expression andfunction through suppression of NF-kB activation in breast and pancreatic tumor cells’’ [Biochem. Pharmacol. 80 (2010) 1553–1562].Biochem Pharmacol (2014), http://dx.doi.org/10.1016/j.bcp.2014.04.013